Regulatory changes boost Indian drugmakers
Key Highlights
- Argentina has committed to reduce barriers for Indian pharmaceutical companies.
- The country will work towards upgrading India under its pharmaceutical regulatory framework.
- The discussions took place during the India-Argentina Joint Trade Committee meeting.
- Bilateral trade between India and Argentina crossed $6.5 billion in 2025.
- Mining, energy, infrastructure and lithium were among key areas discussed.
- India and Argentina also identified opportunities in AI, 5G and digital infrastructure.
- India and the Mercosur bloc are working towards expanding their existing trade agreement.
New Delhi, August 29, 2026: Argentina has committed to reducing barriers for Indian pharmaceutical companies seeking to enter its market, a development expected to create new opportunities for India’s pharmaceutical sector and improve access to affordable medicines in the South American country.
The commitment emerged during discussions between India and Argentina as Commerce Secretary Rajesh Agarwal visited Buenos Aires for the India-Argentina Joint Trade Committee meeting.
According to the Commerce Ministry, Argentina has agreed to work towards upgrading India’s status from Annex II to Annex I under its pharmaceutical regulatory framework.
The move is expected to reduce regulatory barriers and facilitate greater participation by Indian pharmaceutical companies in Argentina’s healthcare market.
The discussions were held during the India-Argentina Joint Trade Committee meeting on August 24, 2026, at Palacio San Martin in Buenos Aires.
The two countries also reviewed broader opportunities for strengthening trade and investment ties.
Bilateral trade between India and Argentina crossed $6.5 billion in 2025, with annual growth exceeding 17 per cent.
Investment opportunities across mining, energy and infrastructure were also discussed during the visit.
A major area of cooperation remains India’s involvement in Argentina’s lithium sector. India’s KABIL has continued its engagement in mining activities in Catamarca.
According to the ministry, KABIL’s lithium mining project, described as the first lithium mining initiative by an Indian company in Argentina, has made significant progress with the completion of Phase II drilling.
India and Argentina also identified several emerging areas for future cooperation, including aviation, space technology, telecommunications and digital services.
Technologies such as 5G, artificial intelligence and digital infrastructure were identified as sectors offering additional opportunities for collaboration.
The discussions also come as India and the Mercosur trade bloc seek to expand their existing Preferential Trade Agreement.
Mercosur includes Brazil, Argentina, Uruguay and Paraguay, and the India-Mercosur Preferential Trade Agreement came into effect on June 1, 2009.
Progress on the Terms of Reference for expanding the agreement, along with the adoption of digital certificates of origin, is expected to support smoother cross-border trade and improve efficiency for businesses.
The proposed regulatory changes for Indian pharmaceutical companies could further strengthen India’s economic relationship with Argentina while opening a potentially important South American market for Indian drugmakers.
